Troy A. Ignelzi insider trades: Rapport Therapeutics (RAPP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Troy reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 21, 2026 | RAPP | ↑ Buy | 5,500 | $26.10 | $144K | Direct | Oct 21, 2026 (0d) |
| Mar 13, 2025 | RAPP | ↑ Buy | 10,000 | $10.10 | $101K | Direct | Mar 13, 2025 (0d) |
| Aug 22, 2023 | KRTX | ↓ Sell | 1,500 | $175.12 | $263K | Direct | Aug 24, 2023 (2d) |
| May 23, 2023 | KRTX | ↓ Sell | 9,000 | $223.41 | $2.0M | Direct | May 25, 2023 (2d) |
| Feb 21, 2023 | KRTX | ↓ Sell | 6,000 | $190.01 | $1.1M | Direct | Feb 23, 2023 (2d) |
| Jan 18, 2023 | KRTX | ↓ Sell | 1,017 | $201.16 | $205K | Direct | Jan 19, 2023 (1d) |
| Nov 15, 2022 | KRTX | ↓ Sell | 16,500 | $225.85 | $3.7M | Direct | Nov 17, 2022 (2d) |
| Oct 4, 2022 | KRTX | ↓ Sell | 15,000 | $229.61 | $3.4M | Direct | Oct 4, 2022 (0d) |
| Aug 9, 2022 | KRTX | ↓ Sell | 16,500 | $227.83 | $3.8M | Direct | Aug 11, 2022 (2d) |
| Apr 21, 2022 | KRTX | ↓ Sell | 4,244 | $131.24 | $557K | Direct | Apr 21, 2022 (0d) |
| Feb 15, 2022 | KRTX | ↓ Sell | 1,500 | $111.14 | $167K | Direct | Feb 17, 2022 (2d) |
| Nov 8, 2021 | KRTX | ↓ Sell | 13,500 | $152.32 | $2.1M | Direct | Nov 10, 2021 (2d) |
| Sep 10, 2021 | KRTX | ↓ Sell | 10,000 | $117.38 | $1.2M | Direct | Sep 10, 2021 (0d) |
| Jun 16, 2021 | KRTX | ↓ Sell | 3,500 | $130.13 | $455K | Direct | Jun 16, 2021 (0d) |
| May 12, 2021 | KRTX | ↓ Sell | 7,200 | $110.35 | $794K | Direct | May 12, 2021 (0d) |
| Feb 16, 2021 | KRTX | ↓ Sell | 10,000 | $119.57 | $1.2M | Direct | Feb 17, 2021 (1d) |
| Jan 8, 2021 | KRTX | ↓ Sell | 8,000 | $104.49 | $836K | Direct | Jan 12, 2021 (4d) |
| Nov 10, 2020 | KRTX | ↓ Sell | 10,000 | $105.61 | $1.1M | Direct | Nov 10, 2020 (0d) |
| Sep 8, 2020 | KRTX | ↓ Sell | 2,000 | $73.30 | $147K | Direct | Sep 10, 2020 (2d) |
| Jul 8, 2020 | KRTX | ↓ Sell | 8,000 | $98.74 | $790K | Direct | Jul 10, 2020 (2d) |
| Jun 16, 2020 | KRTX | ↓ Sell | 8,000 | $92.31 | $738K | Direct | Jun 17, 2020 (1d) |
| May 8, 2020 | KRTX | ↓ Sell | 7,500 | $83.38 | $625K | Direct | May 12, 2020 (4d) |
| Mar 2, 2020 | KRTX | ↓ Sell | 7,500 | $86.50 | $649K | Direct | Mar 4, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RAPP insiders
Open-market trades in the last 12 months
About Troy A. Ignelzi's insider trades
Troy A. Ignelzi is Chief Financial Officer at Rapport Therapeutics (RAPP). Since Mar 2, 2020, Troy has reported 2 open-market purchases worth $245K and 21 sales worth $25.8M on SEC Form 4. In the last 12 months: 1 buy ($144K).
Their filings also include option exercises (25 filings), grants and awards (12 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RAPP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.